VANCOUVER AND MESA, AZ, Nov. 28, 2012 /PRNewswire/ - Asantae Holdings International Inc. (TSXV: JVA), (OTC PINK: ASNHF), (the "Company") a leading producer and marketer of innovative nutritional products through direct and network marketing channels, today announced that it has been invited to present at the 5th Annual LD MICRO Conference, held December 5-6, 2012 at the Luxe Sunset Bel Air Hotel, Los Angeles. Asantae's COO, Daniel Lundell, will present on Thursday, Dec. 6, 2012 at 11am PST (Track 4) and is available for one-on-one meetings on Dec. 5-6. About Asantae Asantae Holdings International Inc. ( www.asantae.com) is a producer and marketer of innovative nutritional products through a network of independent distributors (Asantae Independent Affiliates). Asantae's flagship product RealW8™ addresses the primary threat to public health in the industrialized world; overweight and obesity. Asantae's approach to this threat is based on a body of research related to the brain chemistry of addiction, chronic low-grade inflammation and oxidative stresses which, according to scientific and medical research, are the underlying conditions for most modern epidemic diseases (obesity, heart disease, diabetes, stroke, some cancers, etc.). According to Market data Enterprises, Inc., the U.S. weight loss market alone is estimated at $60.9 billion per year. About LD MICRO LD MICRO is a by-invitation only newsletter firm that focuses on finding undervalued companies in the micro-cap space. Since 2002, the firm has published an annual list of recommended stocks as well as comprehensive reports on select companies throughout the year. LD MICRO concentrates on finding, researching, and investing in companies that are overlooked by institutional investors. It is a non-registered investment advisor. To register, please call 408-457-1042 or e-mail Chris@ldmicro.com. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.